Drug therapy versus rehabilitation for the management of patients with balance disorders following head trauma

Non pharmacologic versus pharmacologic management of patients with balance disorders following head trauma. A randomised clinical trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2013082814503N1

Enrollment

Registered

2013-09-20

Start date

2013-09-01

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

balance disorders. Disorder of vestibular function, unspecified Vertiginous syndrome NOS

Interventions

Intervention 1: betahistine dihydrochloride tab 48 mg/day in addition to standard vestibular rehabilitation program based on the work of Shepard and Telian.. Each patient will receive an individual

Rehabilitation

Treatment - Drugs

betahistine dihydrochloride tab 48 mg/day in addition to standard vestibular rehabilitation program based on the work of Shepard and Telian.. Each patient will receive an individualized program

Only betahistine dihydrochloride tab 48 mg/day

Only standard vestibular rehabilitation program based on the work of Shepard and Telian.

Eligibility

Sex/Gender

All

Age

20 Years to 50 Years

Inclusion criteria

Inclusion criteria: Included patients had no previous complaints of balance disorders of otologic or other cause, and had taken no sedating drugs or tranquilizers.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Imbalance. Timepoint: undetrmined. Method of measurement: Videonystagmography.	—

Secondary

Measure	Time frame
Vomiting. Timepoint: undetermined. Method of measurement: subjective.	—

Countries

Saudi Arabia

Contacts

Public ContactMaged B Naguib

Suez Canal University

magednaguib@ud.edu.sa00966

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026